Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.61 |
| ▸ | HPGD | P15428 | 2/20 | 0.61 |
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | CES2 | O00748 | 3/20 | 0.56 |
| ▸ | CES1 | P23141 | 3/20 | 0.56 |
| ▸ | PKM | P14618 | 2/20 | 0.50 |
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | ATM | Q13315 | 2/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.48 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.48 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.48 |
| ▸ | GSK3B | P49841 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL29018542 | 0.98 | ALDH1A1 (0.59) | ALDH1A1SMN1; SMN2HPGDLMNACES2 | |
| SCHEMBL16574187 | 0.93 | ALDH1A1 (0.55) | ALDH1A1SMN1; SMN2HPGDLMNACES2 | |
| Toluene SCHEMBL5367894 | 0.91 | CES2 (0.57) | ALDH1A1SMN1; SMN2HPGDLMNACES2 | |
| SCHEMBL1004649 | 0.89 | ALDH1A1 (0.73) | ALDH1A1SMN1; SMN2HPGDLMNAHTT | |
| SCHEMBL5612757 | 0.88 | HPGD (0.85) | ALDH1A1SMN1; SMN2HPGDLMNACES2 | |
| SCHEMBL11216329 | 0.85 | ALDH1A1 (0.56) | ALDH1A1SMN1; SMN2HPGDLMNACES2 | |
| Toluene SCHEMBL27540980 | 0.84 | CES2 (0.54) | ALDH1A1SMN1; SMN2HPGDLMNACES2 | |
| SCHEMBL93592 | 0.83 | ALDH1A1 (0.54) | ALDH1A1SMN1; SMN2HPGDLMNACES2 | |
| SCHEMBL4711272 | 0.82 | ALDH1A1 (0.59) | ALDH1A1SMN1; SMN2HPGDLMNACES2 | |
| SCHEMBL10626283 | 0.82 | ALDH1A1 (0.64) | ALDH1A1SMN1; SMN2HPGDLMNATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 888 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119956084-A | Composite extraction system and process for extracting lithium from lithium-containing solution | 中国科学院过程工程研究所 | 2025-05-09 | — | — | CN | claimed |
| CN-113292978-B | Amphoteric two-dimensional nanosheet and preparation method and application thereof | 西南石油大学 | 2022-03-08 | — | — | CN | claimed |
| CN-113737396-A | Breathable stretchable nanofiber composite film material for friction nanogenerator and preparation method thereof | 武汉大学 | 2021-12-03 | — | — | CN | claimed |
| CN-113292978-A | Amphoteric two-dimensional nanosheet and preparation method and application thereof | 西南石油大学 | 2021-08-24 | — | — | CN | claimed |
| CN-111087304-A | Synthesis method of (E) -3- (4-hydroxy-2-methoxyphenyl) methyl acrylate | 晋城天成科创股份有限公司 | 2020-05-01 | — | — | CN | claimed |
| CN-111040054-A | Catalyst component for olefin polymerization, preparation method, catalyst and application thereof | 中国石油化工股份有限公司 | 2020-04-21 | — | — | CN | claimed |
| US-20160279162-A1 | MICELLE-BASED DELIVERY OF DERMAL THERAPEUTIC MATERIALS | NUVESSE SKIN THERAPIES, INC. | 2016-09-29 | — | — | US | claimed |
| EP-3071188-A1 | MICELLE-BASED DELIVERY OF DERMAL THERAPEUTIC MATERIALS | Polyremedy, Inc. (US) | 2016-09-28 | — | — | EP | claimed |
| WO-2015074082-A1 | MICELLE-BASED DELIVERY OF DERMAL THERAPEUTIC MATERIALS | POLYREMEDY, INC. (US) | 2015-05-21 | — | — | WO | claimed |
| CN-101177411-A | Method for synthesizing non-steroidal antiphlogiston tolmetin | UNIV TIANJIN TECHNOLOGY (CN) | 2008-05-14 | — | — | CN | claimed |
| EP-0813879-B1 | Drug administration composition for iontophoresis | HISAMITSU PHARMACEUTICAL CO (JP) | 2002-10-30 | — | — | EP | claimed |
| US-20020041854-A1 | Cosmetic compositions in powder form comprising a binder, and make-up and cosmetic care methods | L'OREAL S.A. (FR) | 2002-04-11 | — | — | US | claimed |
| US-20020034480-A1 | Make-up compositions comprising a binder phase, and make-up methods | L'OREAL, S.A. (FR) | 2002-03-21 | — | — | US | claimed |
| EP-1155676-A2 | Composition for make-up or skin-care in a powdery form and containing a particular binder | L'OREAL (FR) | 2001-11-21 | — | — | EP | claimed |
| EP-0906093-A1 | ALPHA BLOCKERS (e.g. MOXISYLYTE AND/OR DERIVATIVES THEREOF) FOR TREATING ERECTILE DYSFUNCTION | Biotec Centre S.A. (FR) | 1999-04-07 | — | — | EP | claimed |
| US-5877355-A | 2-hydroxy-5-alkyl-beta-methylstyrene and process of preparing hydroxyarylaldehydes therefrom | HENKEL CORPORATION (US) | 1999-03-02 | — | — | US | claimed |
| US-5846990-A | Substituted biphenyl isoxazole sulfonamides | BRISTOL-MYERS SQUIBB CO. (US) | 1998-12-08 | — | — | US | claimed |
| WO-1997042946-A1 | ALPHA BLOCKERS (e.g. MOXISYLYTE AND/OR DERIVATIVES THEREOF) FOR TREATING ERECTILE DYSFUNCTION | BIOTEC CENTRE S.A. (FR) | 1997-11-20 | — | — | WO | claimed |
| EP-0478874-A2 | Novel 2-substituted alkyl-3-carboxy carbapenems as antibiotics and a method of producing them | AMERICAN CYANAMID COMPANY (US) | 1992-04-08 | — | — | EP | claimed |
| US-4043874-A | TOLUENE, DIMETHYLFORMAMIDE, DISTILLATION | SOCIETA' ITALIANA RESINE S.I.R. S.P.A. (IT) | 1977-08-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020034480-A1 | Make-up compositions comprising a binder phase, and make-up methods | TTR, GRN, MB | ALDH1A1 4185/4885SMN1; SMN2 3682/4885HPGD 1621/4885 |
| US-20020041854-A1 | Cosmetic compositions in powder form comprising a binder, and make-up and cosmetic care methods | CUTA, LAGE3, MITF | ALDH1A1 3033/4885SMN1; SMN2 4190/4885HPGD 3452/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.